Baculovirus: An insect-derived vector for diverse gene transfer applications

Molecular Therapy

Volumn 21, Issue 4, 2013, Pages 739-749

  Airenne, Kari J ^a   Hu, Yu Chen ^b   Kost, Thomas A ^c   Smith, Richard H ^d   Kotin, Robert M ^d   Ono, Chikako ^e   Matsuura, Yoshiharu ^e   Wang, Shu ^f,g   Ylä Herttuala, Seppo ^a,h  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^c GLAXOSMITHKLINE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e OSAKA UNIVERSITY   (Japan)

^f INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^h KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACULOVIRUS VECTOR; BUTYRIC ACID; HISTONE DEACETYLASE INHIBITOR; RECOMBINANT PROTEIN; SIPULEUCEL T; TRICHOSTATIN A; VALPROIC ACID; VIRUS VECTOR; WART VIRUS VACCINE;

AUTOGRAPHA CALIFORNICA; BIOTECHNOLOGY; CANCER GENE THERAPY; CELL DIVISION; CROP PROTECTION; DRUG DEVELOPMENT; EX VIVO GENE TRANSFER; EXPRESSION VECTOR; FOREST; GENE TRANSFER; HUMAN; IN VITRO GENE TRANSFER; INSECT; INSECT CELL; NONHUMAN; PROTEIN SYNTHESIS; REVIEW; STEM CELL; TISSUE ENGINEERING; VACCINATION; VERTEBRATE; VIRAL GENE DELIVERY SYSTEM;

ANIMALIA; HEXAPODA; VERTEBRATA;

EID: 84878549291     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.286     Document Type: Review

References (150)

1. Boztug, K, Schmidt, M, Schwarzer, A, Banerjee, P P, Díez, IA, Dewey, RA et al. (2010). Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med 363: 1918-1927.
2. Hacein-Bey-Abina, S, Hauer, J, Lim, A, Picard, C, Wang, GP, Berry, CC et al. (2010). Effcacy of gene therapy for X-linked severe combined immunodefciency. N Engl J Med 363: 355-364.
3. Friedrich, MJ (2010). Seeing is believing: gene therapy shows promise for ocular disorders. JAMA 304: 1543-1545.
4. Immonen, A, Vapalahti, M, Tyynelä, K, Hurskainen, H, Sandmair, A, Vanninen, R et al. (2004). AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol Ther 10: 967-972.
5. Giacca, M and Zacchigna, S (2012). Virus-mediated gene delivery for human gene therapy. J Control Release 161: 377-388.
6. Summers, MD (2006). Milestones leading to the genetic engineering of baculoviruses as expression vector systems and viral pesticides. Adv Virus Res 68: 3-73.
7. Kost, TA, Condreay, JP and Jarvis, DL (2005). Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23: 567-575.
8. Airenne, KJ, Mähönen, AJ, Laitinen, OH and Ylä-Herttuala, S (2009). Baculovirus-mediated gene transfer: An emerging universal concept. In: Templeton, NS (ed.). Gene and cell therapy: Therapeutic Mechanisms and Strategies, 3rd edn. CRC Press: Boca Raton. pp. 263-307.
9. Chen, CY, Lin, CY, Chen, GY and Hu, YC (2011). Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol Adv 29: 618-631.
10. Theilmann, DA, Blissard, GW, Bonning, B, Jehle, J, O'Reilly, DR, Rohrmann, GF et al. (2005). Family Baculoviridae. In: Fauquet, CM, Mayo, MA, Maniloff, J, Desselberger, U, Ball, LA (eds.). Virus Taxonomy: Eight Report of the International Committee on Taxonomy of Viruses. Elsevier: London. pp. 177-185.
11. O'Reilly, DR, Miller, LK and Luckov, VA (1994). Baculovirus Expression Vectors. A Laboratory Manual. Oxford University Press: New York.
12. Burges, HD, Croizier G and Huger, J (1980). A review of safety tests on baculoviruses. Entomaphaga 25: 329-340.
13. Kost, TA and Condreay, JP (2002). Innovations-Biotechnology: Baculovirus vectors as gene transfer vectors for mammlian cells: Biosafety considerations. J Am Biol Safety Ass 7: 167-169.
14. Jehle, JA, Blissard, GW, Bonning, BC, Cory, JS, Herniou, EA, Rohrmann, GF et al. (2006). On the classifcation and nomenclature of baculoviruses: a proposal for revision. Arch Virol 151: 1257-1266.
15. Cheshenko, N, Krougliak, N, Eisensmith, RC and Krougliak, VA (2001). A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther 8: 846-854.
16. Bieniossek, C, Imasaki, T, Takagi, Y and Berger, I (2012). MultiBac: expanding the research toolbox for multiprotein complexes. Trends Biochem Sci 37: 49-57.
17. Hofmann, C, Sandig, V, Jennings, G, Rudolph, M, Schlag, P and Strauss, M (1995). Effcient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 92: 10099-10103.
18. Boyce, FM and Bucher, NL (1996). Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 93: 2348-2352.
19. Airenne, KJ (2009). Optimization of baculovirus-mediated gene delivery into vertebrate cells. BioProcessing J 8: 54-59.
20. Takata, Y, Kishine, H, Sone, T, Andoh, T, Nozaki, M, Poderycki, M et al. (2011). Generation of iPS cells using a BacMam multigene expression system. Cell Struct Funct 36: 209-222.
21. Airenne, KJ, Peltomaa, E, Hytönen, V P, Laitinen, OH and Ylä-Herttuala, S (2003). Improved generation of recombinant baculovirus genomes in Escherichia coli. Nucleic Acids Res 31: e101.
22. Heikura, T, Nieminen, T, Roschier, MM, Karvinen, H, Kaikkonen, MU, Mähönen, AJ et al. (2012). Baculovirus-mediated vascular endothelial growth factor-D(NC) gene transfer induces angiogenesis in rabbit skeletal muscle. J Gene Med 14: 35-43.
23. Aucoin, MG, Mena, JA and Kamen, AA (2010). Bioprocessing of baculovirus vectors: a review. Curr Gene Ther 10: 174-186.
24. Vicente, T, Peixoto, C, Carrondo, MJ and Alves, PM (2009). Purifcation of recombinant baculoviruses for gene therapy using membrane processes. Gene Ther 16: 766-775.
25. Airenne, KJ, Makkonen, KE, Mähönen, AJ and Ylä-Herttuala, S (2010). In vivo application and tracking of baculovirus. Curr Gene Ther 10: 187-194.
26. Madhan, S, Prabakaran, M and Kwang, J (2010). Baculovirus as vaccine vectors. Curr Gene Ther 10: 201-213.
27. Wang, S and Balasundaram, G (2010). Potential cancer gene therapy by baculoviral transduction. Curr Gene Ther 10: 214-225.
28. Lin, CY, Lu, CH, Luo, WY, Chang, YH, Sung, LY, Chiu, HY et al. (2010). Baculovirus as a gene delivery vector for cartilage and bone tissue engineering. Curr Gene Ther 10: 242-254.
29. Lesch, HP, Makkonen, KE, Laitinen, A, Määttä, AM, Närvänen, O, Airenne, KJ et al. (2011). Requirements for baculoviruses for clinical gene therapy applications. J Invertebr Pathol 107 Suppl: S106-S112.
30. Ayres, MD, Howard, SC, Kuzio, J, Lopez-Ferber, M and Possee, RD (1994). The complete DNA sequence of Autographa californica nuclear polyhedrosis virus. Virology 202: 586-605.
31. Kärkkäinen, HR, Lesch, HP, Määttä, AI, Toivanen, PI, Mähönen, AJ, Roschier, MM et al. (2009). A 96-well format for a high-throughput baculovirus generation, fast titering and recombinant protein production in insect and mammalian cells. BMC Res Notes 2: 63.
32. Jarvis, DL and Garcia, A Jr (1994). Long-term stability of baculoviruses stored under various conditions. BioTechniques 16: 508-513.
33. Wasilko, DJ and Lee, SE (2006). TIPS: Titerless infected-cells preservation and scale up. BioProcessing J 5: 29-32.
34. Federici, BA (1997). Baculovirus Pathogenesis. In: Miller, LK (ed.). The Baculoviruses, 1 edn. Plenum Press: New York. pp 33-59.
35. Funk, CJ, Braunagel, SC and Rohrmann, GF (1997). Baculovirus Structure. In: Miller, LK (ed.). The Baculoviruses, 1 edn. Plenum Press: New York. pp 7-32.
36. Laakkonen, JP, Mäkelä, AR, Kakkonen, E, Turkki, P, Kukkonen, S, Peränen, J et al. (2009). Clathrin-independent entry of baculovirus triggers uptake of E. coli in non-phagocytic human cells. PLoS ONE 4: e5093.
37. Matilainen, H, Rinne, J, Gilbert, L, Marjomäki, V, Reunanen, H and Oker-Blom, C (2005). Baculovirus entry into human hepatoma cells. J Virol 79: 15452-15459.
38. Long, G, Pan, X, Kormelink, R and Vlak, JM (2006). Functional entry of baculovirus into insect and mammalian cells is dependent on clathrin-mediated endocytosis. J Virol 80: 8830-8833.
39. Kataoka, C, Kaname, Y, Taguwa, S, Abe, T, Fukuhara, T, Tani, H et al. (2012). Baculovirus GP64-mediated entry into mammalian cells. J Virol 86: 2610-2620.
40. van Loo, ND, Fortunati, E, Ehlert, E, Rabelink, M, Grosveld, F and Scholte, BJ (2001). Baculovirus infection of nondividing mammalian cells: mechanisms of entry and nuclear transport of capsids. J Virol 75: 961-970.
41. Blissard, GW (1996). Baculovirus-insect cell interactions. Cytotechnology 20: 73-93.
42. Kukkonen, S P, Airenne, KJ, Marjomäki, V, Laitinen, OH, Lehtolainen, P, Kankaanpää, P et al. (2003). Baculovirus capsid display: a novel tool for transduction imaging. Mol Ther 8: 853-862.
43. Ohkawa, T, Volkman, LE and Welch, MD (2010). Actin-based motility drives baculovirus transit to the nucleus and cell surface. J Cell Biol 190: 187-195.
44. Goley, ED, Ohkawa, T, Mancuso, J, Woodruff, JB, D'Alessio, JA, Cande, WZ et al. (2006). Dynamic nuclear actin assembly by Arp2/3 complex and a baculovirus WASPlike protein. Science 314: 464-467.
45. Laakkonen, JP, Kaikkonen, MU, Ronkainen, PH, Ihalainen, TO, Niskanen, EA, Häkkinen, M et al. (2008). Baculovirus-mediated immediate-early gene expression and nuclear reorganization in human cells. Cell Microbiol 10: 667-681.
46. Au, S and Panté, N (2012). Nuclear transport of baculovirus: revealing the nuclear pore complex passage. J Struct Biol 177: 90-98.
47. Salminen, M, Airenne, KJ, Rinnankoski, R, Reimari, J, Välilehto, O, Rinne, J et al. (2005). Improvement in nuclear entry and transgene expression of baculoviruses by disintegration of microtubules in human hepatocytes. J Virol 79: 2720-2728.
48. Volkman, LE and Goldsmith, PA (1983). In Vitro Survey of Autographa californica Nuclear Polyhedrosis Virus Interaction with Nontarget Vertebrate Host Cells. Appl Environ Microbiol 45: 1085-1093.
49. Spenger, A, Ernst, W, Condreay, J P, Kost, TA and Grabherr, R (2004). Infuence of promoter choice and trichostatin A treatment on expression of baculovirus delivered genes in mammalian cells. Protein Expr Purif 38: 17-23.
50. Hsu, CS, Ho, YC, Wang, KC and Hu, YC (2004). Investigation of optimal transduction conditions for baculovirus-mediated gene delivery into mammalian cells. Biotechnol Bioeng 88: 42-51.
51. Mähönen, AJ, Makkonen, KE, Laakkonen, J P, Ihalainen, TO, Kukkonen, SP, Kaikkonen, MU et al. (2010). Culture medium induced vimentin reorganization associates with enhanced baculovirus-mediated gene delivery. J Biotechnol 145: 111-119.
52. Lesch, HP, Laitinen, A, Peixoto, C, Vicente, T, Makkonen, KE, Laitinen, L et al. (2011). Production and purifcation of lentiviral vectors generated in 293T suspension cells with baculoviral vectors. Gene Ther 18: 531-538.
53. Lesch, HP, Turpeinen, S, Niskanen, EA, Mähönen, AJ, Airenne, KJ and Ylä-Herttuala, S (2008). Generation of lentivirus vectors using recombinant baculoviruses. Gene Ther 15: 1280-1286.
54. Luo, WY, Shih, YS, Hung, CL, Lo, KW, Chiang, CS, Lo, WH et al. (2012). Development of the hybrid Sleeping Beauty: baculovirus vector for sustained gene expression and cancer therapy. Gene Ther 19: 844-851.
55. Mähönen, AJ, Airenne, KJ, Purola, S, Peltomaa, E, Kaikkonen, MU, Riekkinen, MS et al. (2007). Post-transcriptional regulatory element boosts baculovirus-mediated gene expression in vertebrate cells. J Biotechnol 131: 1-8.
56. Condreay, JP, Witherspoon, SM, Clay, WC and Kost, TA (1999). Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 96: 127-132.
57. Mäkelä, AR and Oker-Blom, C (2008). The baculovirus display technology-an evolving instrument for molecular screening and drug delivery. Comb Chem High Throughput Screen 11: 86-98.
58. Tani, H, Limn, CK, Yap, CC, Onishi, M, Nozaki, M, Nishimune, Y et al. (2003). In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol 77: 9799-9808.
59. Barsoum, J, Brown, R, McKee, M and Boyce, FM (1997). Effcient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther 8: 2011-2018.
60. Kaikkonen, MU, Räty, JK, Airenne, KJ, Wirth, T, Heikura, T and Ylä-Herttuala, S (2006). Truncated vesicular stomatitis virus G protein improves baculovirus transduction effciency in vitro and in vivo. Gene Ther 13: 304-312.
61. Kaikkonen, MU, Ylä-Herttuala, S and Airenne, KJ (2011). How to avoid complement attack in baculovirus-mediated gene delivery. J Invertebr Pathol 107 Suppl: S71-S79.
62. Strauss, R, Hüser, A, Ni, S, Tuve, S, Kiviat, N, Sow, PS et al. (2007). Baculovirus-based vaccination vectors allow for effcient induction of immune responses against plasmodium falciparum circumsporozoite protein. Mol Ther 15: 193-202.
63. Hofmann, C and Strauss, M (1998). Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther 5: 531-536.
64. Georgopoulos, LJ, Elgue, G, Sanchez, J, Dussupt, V, Magotti, P, Lambris, JD et al. (2009). Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood. Mol Immunol 46: 2911-2917.
65. Airenne, KJ, Hiltunen, MO, Turunen, MP, Turunen, AM, Laitinen, OH, Kulomaa, MS et al. (2000). Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther 7: 1499-1504.
66. Sarkis, C, Serguera, C, Petres, S, Buchet, D, Ridet, JL, Edelman, L et al. (2000). Effcient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc Natl Acad Sci USA 97: 14638-14643.
67. Sandig, V, Hofmann, C, Steinert, S, Jennings, G, Schlag, P and Strauss, M (1996). Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum Gene Ther 7: 1937-1945.
68. Murguía-Meca, F, Plata-Muñoz, JJ, Hitchman, RB, Danquah, JO, Hughes, D, Friend, PJ et al. (2011). Baculovirus as delivery system for gene transfer during hypothermic organ preservation. Transpl Int 24: 820-828.
69. Paul, A, Binsalamah, ZM, Khan, AA, Abbasia, S, Elias, CB, Shum-Tim, D et al. (2011). A nanobiohybrid complex of recombinant baculovirus and Tat/DNA nanoparticles for delivery of Ang-1 transgene in myocardial infarction therapy. Biomaterials 32: 8304-8318.
70. Kim, YK, Kwon, JT, Choi, JY, Jiang, HL, Arote, R, Jere, D et al. (2010). Suppression of tumor growth in xenograft model mice by programmed cell death 4 gene delivery using folate-PEG-baculovirus. Cancer Gene Ther 17: 751-760.
71. Suzuki, T, Oo Chang, M, Kitajima, M and Takaku, H (2010). Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells. Cell Mol Immunol 7: 440-446.
72. Guo, H, Choudhury, Y, Yang, J, Chen, C, Tay, FC, Lim, TM et al. (2011). Antiglioma effects of combined use of a baculovirual vector expressing wild-type p53 and sodium butyrate. J Gene Med 13: 26-36.
73. Hoare, J, Waddington, S, Thomas, HC, Coutelle, C and McGarvey, MJ (2005). Complement inhibition rescued mice allowing observation of transgene expression following intraportal delivery of baculovirus in mice. J Gene Med 7: 325-333.
74. Hofmann, C, Hüser, A, Lehnert, W and Strauss, M (1999). Protection of baculovirus-vectors against complement-mediated inactivation by recombinant soluble complement receptor type 1. Biol Chem 380: 393-395.
75. Yang, Y, Lo, SL, Yang, J, Yang, J, Goh, SS, Wu, C et al. (2009). Polyethylenimine coating to produce serum-resistant baculoviral vectors for in vivo gene delivery. Biomaterials 30: 5767-5774.
76. Li, Y, Wang, X, Guo, H and Wang, S (2004). Axonal transport of recombinant baculovirus vectors. Mol Ther 10: 1121-1129.
77. Lehtolainen, P, Tyynelä, K, Kannasto, J, Airenne, KJ and Ylä-Herttuala, S (2002). Baculoviruses exhibit restricted cell type specifcity in rat brain: a comparison of baculovirus-and adenovirus-mediated intracerebral gene transfer in vivo. Gene Ther 9: 1693-1699.
78. Pieroni, L, Maione, D and La Monica, N (2001). In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum Gene Ther 12: 871-881.
79. Haeseleer, F, Imanishi, Y, Saperstein, DA and Palczewski, K (2001). Gene transfer mediated by recombinant baculovirus into mouse eye. Invest Ophthalmol Vis Sci 42: 3294-3300.
80. Kinnunen, K, Kalesnykas, G, Mähönen, AJ, Laidinen, S, Holma, L, Heikura, T et al. (2009). Baculovirus is an effcient vector for the transduction of the eye: comparison of baculovirus-and adenovirus-mediated intravitreal vascular endothelial growth factor D gene transfer in the rabbit eye. J Gene Med 11: 382-389.
81. Kim, CH, Yoon, JS, Sohn, HJ, Kim, CK, Paik, SY, Hong, YK et al. (2007). Direct vaccination with pseudotype baculovirus expressing murine telomerase induces anti-tumor immunity comparable with RNA-electroporated dendritic cells in a murine glioma model. Cancer Lett 250: 276-283.
82. Kitajima, M, Abe, T, Miyano-Kurosaki, N, Taniguchi, M, Nakayama, T and Takaku, H (2008). Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus. Mol Ther 16: 261-268.
83. Kaname, Y, Tani, H, Kataoka, C, Shiokawa, M, Taguwa, S, Abe, T et al. (2010). Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64. J Virol 84: 3210-3219.
84. Kaikkonen, MU, Maatta, AI, Ylä-Herttuala, S and Airenne, KJ (2010). Screening of complement inhibitors: shielded baculoviruses increase the safety and effcacy of gene delivery. Mol Ther 18: 987-992.
85. Schauber, CA, Tuerk, MJ, Pacheco, CD, Escarpe, PA and Veres, G (2004). Lentiviral vectors pseudotyped with baculovirus gp64 effciently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro. Gene Ther 11: 266-275.
86. Sinn, PL, Burnight, ER, Hickey, MA, Blissard, GW and McCray, PB Jr (2005). Persistent gene expression in mouse nasal epithelia following feline immunodefciency virus-based vector gene transfer. J Virol 79: 12818-12827.
87. Hu, YC, Yao, K and Wu, TY (2008). Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev Vaccines 7: 363-371.
88. Tani, H, Abe, T, Matsunaga, TM, Moriishi, K and Matsuura, Y (2008). Baculovirus vector for gene delivery and vaccine development. Future Virol 3: 35-43.
89. McMichael, AJ, Borrow, P, Tomaras, GD, Goonetilleke, N and Haynes, BF (2010). The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 10: 11-23.
90. Abe, T, Takahashi, H, Hamazaki, H, Miyano-Kurosaki, N, Matsuura, Y and Takaku, H (2003). Baculovirus induces an innate immune response and confers protection from lethal infuenza virus infection in mice. J Immunol 171: 1133-1139.
91. Abe, T, Hemmi, H, Miyamoto, H, Moriishi, K, Tamura, S, Takaku, H et al. (2005). Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus. J Virol 79: 2847-2858.
92. Abe, T, Kaname, Y, Wen, X, Tani, H, Moriishi, K, Uematsu, S et al. (2009). Baculovirus induces type I interferon production through toll-like receptor-dependent and-independent pathways in a cell-type-specifc manner. J Virol 83: 7629-7640.
93. Ho, YC, Chung, YC, Hwang, SM, Wang, KC and Hu, YC (2005). Transgene expression and differentiation of baculovirus-transduced human mesenchymal stem cells. J Gene Med 7: 860-868.
94. Bak, XY, Yang, J and Wang, S (2010). Baculovirus-transduced bone marrow mesenchymal stem cells for systemic cancer therapy. Cancer Gene Ther 17: 721-729.
95. Lin, CY, Lin, KJ, Kao, CY, Chen, MC, Lo, WH, Yen, TC et al. (2011). The role of adipose-derived stem cells engineered with the persistently expressing hybrid baculovirus in the healing of massive bone defects. Biomaterials 32: 6505-6514.
96. Bak, XY, Lam, DH, Yang, J, Ye, K, Wei, EL, Lim, SK et al. (2011). Human embryonic stem cell-derived mesenchymal stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma. Hum Gene Ther 22: 1365-1377.
97. Zeng, J, Du, J, Lin, J, Bak, XY, Wu, C and Wang, S (2009). High-effciency transient transduction of human embryonic stem cell-derived neurons with baculoviral vectors. Mol Ther 17: 1585-1593.
98. Zhao, Y, Lam, DH, Yang, J, Lin, J, Tham, CK, Ng, WH et al. (2012). Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modifed by baculoviral vectors. Gene Ther 19: 189-200.
99. Zeng, J, Du, J, Zhao, Y, Palanisamy, N and Wang, S (2007). Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells. Stem Cells 25: 1055-1061.
100. Lei, Y, Lee, CL, Joo, KI, Zarzar, J, Liu, Y, Dai, B et al. (2011). Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-fnger nucleases. Mol Ther 19: 942-950.
101. Ramachandra, CJ, Shahbazi, M, Kwang, TW, Choudhury, Y, Bak, XY, Yang, J et al. (2011). Effcient recombinase-mediated cassette exchange at the AAVS1 locus in human embryonic stem cells using baculoviral vectors. Nucleic Acids Res 39: e107.
102. Chen, GY, Pang, DW, Hwang, SM, Tuan, HY and Hu, YC (2012). A graphene-based platform for induced pluripotent stem cells culture and differentiation. Biomaterials 33: 418-427.
103. Chen, GY, Hwang, SM, Su, HJ, Kuo, CY, Luo, WY, Lo, KW et al. (2012). Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction. J Virol 86: 8041-8049.
104. Kotin, RM, Menninger, JC, Ward, DC and Berns, KI (1991). Mapping and direct visualization of a region-specifc viral DNA integration site on chromosome 19q13-qter. Genomics 10: 831-834.
105. Chen, HC, Lee, HP, Ho, YC, Sung, ML and Hu, YC (2006). Combination of baculovirus-mediated gene transfer and rotating-shaft bioreactor for cartilage tissue engineering. Biomaterials 27: 3154-3162.
106. Sung, LY, Lo, WH, Chiu, HY, Chen, HC, Chung, CK, Lee, HP et al. (2007). Modulation of chondrocyte phenotype via baculovirus-mediated growth factor expression. Biomaterials 28: 3437-3447.
107. Sung, LY, Chiu, HY, Chen, HC, Chen, YL, Chuang, CK and Hu, YC (2009). Baculovirus-mediated growth factor expression in dedifferentiated chondrocytes accelerates redifferentiation: effects of combinational transduction. Tissue Eng Part A 15: 1353-1362.
108. Chen, HC, Sung, LY, Lo, WH, Chuang, CK, Wang, YH, Lin, JL et al. (2008). Combination of baculovirus-expressed BMP-2 and rotating-shaft bioreactor culture synergistically enhances cartilage formation. Gene Ther 15: 309-317.
109. Chen, HC, Chang, YH, Chuang, CK, Lin, CY, Sung, LY, Wang, YH et al. (2009). The repair of osteochondral defects using baculovirus-mediated gene transfer with de-differentiated chondrocytes in bioreactor culture. Biomaterials 30: 674-681.
110. Lo, WH, Hwang, SM, Chuang, CK, Chen, CY and Hu, YC (2009). Development of a hybrid baculoviral vector for sustained transgene expression. Mol Ther 17: 658-666.
111. Chuang, CK, Lin, KJ, Lin, CY, Chang, YH, Yen, TC, Hwang, SM et al. (2010). Xenotransplantation of human mesenchymal stem cells into immunocompetent rats for calvarial bone repair. Tissue Eng Part A 16: 479-488.
112. Lin, CY, Chang, YH, Lin, KJ, Yen, TC, Tai, CL, Chen, CY et al. (2010). The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells. Biomaterials 31: 3222-3230.
113. Lin, CY, Chang, YH, Kao, CY, Lu, CH, Sung, LY, Yen, TC et al. (2012). Augmented healing of critical-size calvarial defects by baculovirus-engineered MSCs that persistently express growth factors. Biomaterials 33: 3682-3692.
114. Chen, CY, Wu, HH, Chen, CP, Chern, SR, Hwang, SM, Huang, SF et al. (2011). Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors. Mol Pharm 8: 1505-1514.
115. Luo, WY, Shih, YS, Lo, WH, Chen, HR, Wang, SC, Wang, CH et al. (2011). Baculovirus vectors for antiangiogenesis-based cancer gene therapy. Cancer Gene Ther 18: 637-645.
116. Hervas-Stubbs, S, Rueda, P, Lopez, L and Leclerc, C (2007). Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol 178: 2361-2369.
117. Kitajima, M and Takaku, H (2008). Induction of antitumor acquired immunity by baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mice. Clin Vaccine Immunol 15: 376-378.
118. Zeng, J, Shahbazi, M, Wu, C, Toh, HC and Wang, S (2012). Enhancing immunostimulatory function of human embryonic stem cell-derived dendritic cells by CD1d overexpression. J Immunol 188: 4297-4304.
119. Lotze, MT and Kost, TA (2002). Viruses as gene delivery vectors: application to gene function, target validation, and assay development. Cancer Gene Ther 9: 692-699.
120. Ames, RS and Lu, Q (2009). Viral-mediated gene delivery for cell-based assays in drug discovery. Expert Opin Drug Dis 4: 243-256.
121. Vijayachandran, LS, Viola, C, Garzoni, F, Trowitzsch, S, Bieniossek, C, Chaillet, M et al. (2011). Robots, pipelines, polyproteins: enabling multiprotein expression in prokaryotic and eukaryotic cells. J Struct Biol 175: 198-208.
122. Drugmand, JC, Schneider, YJ and Agathos, SN (2012). Insect cells as factories for biomanufacturing. Biotechnol Adv 30: 1140-1157.
123. Kost, TA, Condreay, JP, Ames, RS, Rees, S and Romanos, MA (2007). Implementation of BacMam virus gene delivery technology in a drug discovery setting. Drug Discov Today 12: 396-403.
124. Kost, TA, Condreay, JP and Ames, RS (2010). Baculovirus gene delivery: a fexible assay development tool. Curr Gene Ther 10: 168-173.
125. Davenport, EA, Nuthulaganti, P and Ames, RS (2009). BacMam: versatile gene delivery technology for GPCR assays. Methods Mol Biol 552: 199-211.
126. Condreay, JP and Watson, CA (2010). Pharmacological applications of baculovirus-mediated protein expression in mammalian cells. Curr Protoc Pharmacol Chapter 6: Unit 6.11.
127. Shukla, S, Schwartz, C, Kapoor, K, Kouanda, A and Ambudkar, SV (2012). Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells. Drug Metab Dispos 40: 304-312.
128. Hassan, NJ, Pountney, DJ, Ellis, C and Mossakowska, DE (2006). BacMam recombinant baculovirus in transporter expression: a study of BCRP and OATP1B1. Protein Expr Purif 47: 591-598.
129. Pfohl, JL, Worley, JF 3rd, Condreay, J P, An, G, Apolito, CJ, Kost, TA et al. (2002). Titration of KATP channel expression in mammalian cells utilizing recombinant baculovirus transduction. Recept Channels 8: 99-111.
130. Beacham, DW, Blackmer, T, O' Grady, M and Hanson, GT (2010). Cell-based potassium ion channel screening using the FluxOR assay. J Biomol Screen 15: 441-446.
131. Machleidt, T, Robers, MB, Hermanson, SB, Dudek, JM and Bi, K (2011). TR-FRET cellular assays for interrogating posttranslational modifcations of histone H3. J Biomol Screen 16: 1236-1246.
132. Xie, W, Pao, C, Graham, T, Dul, E, Lu, Q, Sweitzer, TD et al. (2012). Development of a cell-based high throughput luciferase enzyme fragment complementation assay to identify nuclear-factor-e2-related transcription factor 2 activators. Assay Drug Dev Technol 10: 514-524.
133. Jenkinson, S, McCoy, DC, Kerner, SA, Ferris, RG, Lawrence, WK, Clay, WC et al. (2003). Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology. J Biomol Screen 8: 463-470.
134. Trowitzsch, S, Klumpp, M, Thoma, R, Carralot, JP and Berger, I (2011). Light it up: highly effcient multigene delivery in mammalian cells. Bioessays 33: 946-955.
135. Isom, HC, Abdelhamed, AM, Bilello, JP and Miller, TG (2004). Baculovirus-mediated gene transfer for the study of hepatitis B virus. Methods Mol Med 96: 219-237.
136. Pan, Y, Zhao, Q, Fang, L, Luo, R, Chen, H and Xiao, S (2009). Effcient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cytomegalovirus promoter/Semliki Forest virus replicon. J Gene Med 11: 1030-1038.
137. Li, J, Sun, B, Han, H, Ouyang, J, Yao, H, Yang, Y et al. (2012). Application of baculovirus as a delivery vehicle for study of transcription and translation mechanism of parvovirus in non-permissive mammalian cells. J Virol Methods 183: 1-7.
138. Scott, MJ, Modha, SS, Rhodes, AD, Broadway, NM, Hardwicke, PI, Zhao, HJ et al. (2007). Effcient expression of secreted proteases via recombinant BacMam virus. Protein Expr Purif 52: 104-116.
139. Dukkipati, A, Park, HH, Waghray, D, Fischer, S and Garcia, KC (2008). BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies. Protein Expr Purif 62: 160-170.
140. Urabe, M, Ding, C and Kotin, RM (2002). Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther 13: 1935-1943.
141. Virag, T, Cecchini, S and Kotin, RM (2009). Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy. Hum Gene Ther 20: 807-817.
142. Chejanovsky, N and Carter, BJ (1989). Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication. Virology 173: 120-128.
143. King, JA, Dubielzig, R, Grimm, D and Kleinschmidt, JA (2001). DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. EMBO J 20: 3282-3291.
144. Smith, RH, Levy, JR and Kotin, RM (2009). A simplifed baculovirus-AAV expression vector system coupled with one-step affnity purifcation yields high-titer rAAV stocks from insect cells. Mol Ther 17: 1888-1896.
145. Cecchini, S, Virag, T and Kotin, RM (2011). Reproducible high yields of recombinant adeno-associated virus produced using invertebrate cells in 0.02-to 200-liter cultures. Hum Gene Ther 22: 1021-1030.
146. Dropulic, B (2011). Lentiviral vectors: their molecular design, safety, and use in laboratory and preclinical research. Hum Gene Ther 22: 649-657.
147. Lim, KI (2012). Retroviral integration profles: their determinants and implications for gene therapy. BMB Rep 45: 207-212.
148. Merten, OW, Charrier, S, Laroudie, N, Fauchille, S, Dugué, C, Jenny, C et al. (2011). Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application. Hum Gene Ther 22: 343-356.
149. Cockrell, AS and Kafri, T (2007). Gene delivery by lentivirus vectors. Mol Biotechnol 36: 184-204.
150. Huang, KS, Lo, WH, Chung, YC, Lai, YK, Chen, CY, Chou, ST et al. (2007). Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus. Hum Gene Ther 18: 1161-1170.